CF Industries (CF) Reports Next Week: Wall Street Expects Earnings Growth

Content Krush

Latest on SEO, Content Marketing, Email & Social in Nigeria

MarketingSmall Business

CF Industries (CF) Reports Next Week: Wall Street Expects Earnings Growth

The market expects CF Industries (CF) to notify a Twelve months-over-Twelve months amplify in earnings on elevated revenues when it reports results for the quarter ended September 2021. This widely-known consensus outlook is serious in assessing the corporate’s earnings image, but a highly efficient component that might maybe well influence its come-timeframe stock designate is how the categorical results compare to these estimates.

– Zacks

The earnings file, which is anticipated to be launched on November 3, 2021, might maybe well attend the stock transfer elevated if these key numbers are better than expectations. On the diversified hand, in the event that they miss, the stock might maybe well transfer decrease.

While the sustainability of the instantaneous designate exchange and future earnings expectations will largely rely on administration’s discussion of industry conditions on the earnings name, or no longer it’s price handicapping the probability of a obvious EPS surprise.

Zacks Consensus Estimate

This fertilizer maker is anticipated to put up quarterly earnings of $0.97 per allotment in its upcoming file, which represents a Twelve months-over-Twelve months exchange of +846.2%.

Revenues are expected to be $1.43 billion, up 68.4% from the Twelve months-ago quarter.

Estimate Revisions Model

The consensus EPS estimate for the quarter has been revised 20.27% elevated over the final 30 days to basically the most up-to-date level. Here’s in actual fact a reflection of how the maintaining analysts beget collectively reassessed their preliminary estimates over this duration.

Investors ought to restful take into chronicle that an combination exchange couldn’t consistently mirror the course of estimate revisions by each of the maintaining analysts.

Rate, Consensus and EPS Shock

Earnings Utter

Estimate revisions earlier than a company’s earnings starting up provide clues to the industry conditions for the duration whose results are coming out. Our proprietary surprise prediction model — the Zacks Earnings ESP (Expected Shock Prediction) — has this perception at its core.

The Zacks Earnings ESP compares the Most Precise Estimate to the Zacks Consensus Estimate for the quarter; the Most Precise Estimate is a more most up-to-date version of the Zacks Consensus EPS estimate. The basis here is that analysts revising their estimates correct earlier than an earnings starting up beget basically the most up-to-date info, which might maybe well doubtlessly be more just than what they and others contributing to the consensus had predicted earlier.

Thus, a obvious or unfavorable Earnings ESP finding out theoretically indicates the likely deviation of the categorical earnings from the consensus estimate. Then again, the model’s predictive energy is vital for obvious ESP readings most attention-grabbing.

A obvious Earnings ESP is a sturdy predictor of an earnings beat, particularly when mixed with a Zacks Base #1 (Sturdy Rob), 2 (Rob) or 3 (Defend). Our learn shows that stocks with this aggregate produce a obvious surprise nearly 70% of the time, and a solid Zacks Base in actual fact increases the predictive energy of Earnings ESP.

Please narrate that a unfavorable Earnings ESP finding out is no longer indicative of an earnings miss. Our learn shows that it’s complicated to foretell an earnings beat with any level of self assurance for stocks with unfavorable Earnings ESP readings and/or Zacks Base of 4 (Sell) or 5 (Sturdy Sell).

How Private the Numbers Formed Up for CF?

For CF, the Most Precise Estimate is decrease than the Zacks Consensus Estimate, suggesting that analysts beget today was bearish on the corporate’s earnings potentialities. This has resulted in an Earnings ESP of -4.37%.

On the diversified hand, the stock currently carries a Zacks Base of #3.

So, this aggregate makes it complicated to conclusively predict that CF will beat the consensus EPS estimate.

Does Earnings Shock History Defend Any Clue?

While calculating estimates for an organization’s future earnings, analysts most continuously take into chronicle to what extent it has been in a space to confirm previous consensus estimates. So, or no longer it’s price having a perceive on the surprise historical previous for gauging its influence on the upcoming number.

For the final reported quarter, it became expected that CF would put up earnings of $1.64 per allotment when it in actual fact produced earnings of $1.14, turning in a surprise of -30.49%.

Over the final four quarters, the corporate has beaten consensus EPS estimates two events.

Backside Line

An earnings beat or miss couldn’t be the sole basis for a stock transferring elevated or decrease. Many stocks pause up losing ground despite an earnings beat because of diversified factors that disappoint investors. Similarly, unexpected catalysts attend a form of stocks produce despite an earnings miss.

That acknowledged, having a wager on stocks which shall be expected to beat earnings expectations does amplify the potentialities of success. Here’s why or no longer it’s price checking a company’s Earnings ESP and Zacks Base earlier than its quarterly starting up. Fabricate definite to construct basically the most of our Earnings ESP Filter to provide an clarification for basically the most easy stocks to rep or promote earlier than they’ve reported.

CF doesn’t seem a compelling earnings-beat candidate. Then again, investors ought to restful listen to diversified factors too for having a wager on this stock or staying a long way off from it earlier than its earnings starting up.

Breakout Biotech Shares with Triple-Digit Income Likely

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop therapies for hundreds of illnesses. They’re also finding methods to edit the human genome to literally erase our vulnerability to these illnesses.

Zacks has perfect launched Century of Biology: 7 Biotech Shares to Rob Precise Now to attend investors profit from 7 stocks poised for outperformance. Suggestions from old editions of this file beget produced positive factors of +205%, +258% and +477%. The stocks in this file might maybe well develop even better.

See these 7 leap forward stocks now>>

Prefer basically the most up-to-date concepts from Zacks Investment Be taught? At the moment time, you might maybe well perchance furthermore download 7 Easiest Shares for the Next 30 Days. Click on to secure this free file

 

CF Industries Holdings, Inc. (CF): Free Inventory Evaluation Document

 

To learn this text on Zacks.com click on here.

Comment here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Hide Related Posts